Method and technology for drug repurposing based on changes in the physicochemical properties of dosage forms: experience of use in Russia

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Controlled local hyperthermia and hypothermia are important factors in drug pharmacodynamics and pharmacokinetics because changing the temperature of drugs changes their physicochemical properties. In this regard, a controlled change in the temperature of the drug and/or the body part with which the drug interacts, relative to the level of human body temperature (hyperthermia or hypothermia) forms the basis of temperature pharmacology. To analyze the author’s publications on the problem of methodology and technology for repurposing drugs based on changes in the physicochemical properties of dosage forms. A controlled change in the temperature of the drug and/or the part of the body with which the drug interacts; a change in acid (alkaline), osmotic activity, and the degree and quality of carbonation and/or oxygen-forming activity of medicinal solutions; and a change in the concentration of medicinal solution ingredients. On the basis of the used methods, the reprofiling of a number of drugs has been achieved. The author proposed reprofiling a 4% potassium chloride solution from the group of macroelements and microelements used to regulate acid-base balance with a resorptive effect (when administered intravenously to the whole body) into a group of vasoconstrictive drugs used to stop bleeding when applied to by a single irrigation of the bleeding surface. Cooling certain drugs and tissues at their interaction sites to 18°C–20°C (via an ice pack or its substitute) inhibits metabolism and function, ensuring the conversion of many drugs into anti-ischemic drugs by reducing the need for tissues in oxygen. A targeted change in the physicochemical properties of known drugs combined with local hyperthermia allows them to be converted into expectorant, pyrolytic (astringent), hemolytic, thrombolytic (hemostatic), detergent, bleaching, cleaning, and other drugs, including antiseptic and cauterizing (necrotizing) drugs, very reliably, quickly, and inexpensively. Thus, 40 years ago, pharmacologists of the Russian Federation established the foundation for a novel method of drug development known today as repurposing of existing drugs. Today, it is evident that reprofiling may rapidly, inexpensively, and effectively give existing drugs a new purpose.

Full Text

Restricted Access

About the authors

Alexander L. Urakov

Izhevsk State Medical Academy

Author for correspondence.
Email: urakoval@live.ru
ORCID iD: 0000-0002-9829-9463
SPIN-code: 1613-9660

dr. sci. (med.), professor and head, department of pharmacology

Russian Federation, 281, Kommunarov st., Izhevsk, 426034

References

  1. Frearson JA, Wyatt PG, Gilbert IH, et al. Target assessment for antiparasitic drug discovery. J Trends in Parasitology. 2007;23(12):589–595. doi: 10.1016/j.pt.2007.08.019
  2. Wyatt PG, Gilbert IH, Read KD, et al. Target validation: Linking target and chemical properties to desired product profil. Curr Top Med Chem. 2011;11(10):1275–1283. doi: 10.2174/156802611795429185
  3. Brown M, Bennett P, Sharma P. Discovery and development of drugs. Churchill: Livingstone; 2012.
  4. Urakov AL, Pugach VN, Kravchuk AP, et al. Ispol’zovaniye tepla i kholoda dlya regulyatsii krovotoka i podderzhaniya gemostaza vnutrennikh organov. Patologicheskaya fiziologiya i eksperimental’naya terapiya. 1984;5:43–46. (In Russ.)
  5. Urakov AL. Okhlazhdat’ ili nagrevat’? Priroda. 1986;9:121. (In Russ.)
  6. Urakov AL. Retsept na temperaturu. Izhevsk: Udmurtiya; 1988. (In Russ.)
  7. Urakov AL. Retsept na temperature. Nauka i zhizn’. 1989;9:38–42. (In Russ.)
  8. Urakov AL, Kravchuk AP, Kulik IA, et al. Farmakotermicheskiy sposob ostanovki krovotecheniy. Krovoobrashcheniye. 1989;1:51–53. (In Russ.)
  9. Urakov AL, Kravchuk AP. Temperaturnyy rezhim ranevoy poverkhnosti kak faktor gemostaza. Voyenno-meditsinskiy zhurnal. 1991;8:65–66. (In Russ.)
  10. Urakov AL, Baranov AG, Sutyagin SP, et al. Uluchsheniye krovotoka v organakh i predotvrashcheniye tromboobrazovaniya s pomoshch’yu kholoda. Byulleten’ eksperimental’noy biologii i meditsiny. 1985;7:19–20. (In Russ.)
  11. Urakov AL. Ispol’zovaniye gipotermii dlya izyskaniya printsipial’nykh putey farmakologicheskoy zashchity miokarda ot povrezhdeniya v ranniy period ostroy ishemii. Byulleten’ eksperimental’noy biologii i meditsiny. 1984;4:512. (In Russ.)
  12. Urakov AL, Kravchuk AP. Vliyaniye lokal’noy giper- i gipotermii na gemodinamiku i zhiznesposobnost’ ishemizirovannoy kishki. Vestnik khirurgii imeni I.I. Grekova. 1987;3:43–45. (In Russ.)
  13. Urakov AL, Odiyankov YEG, Murav’yev MF, et al. Vliyaniye temperatury ishemizirovannoy konechnosti na techeniye i prognoz ishemicheskogo porazheniya. Krovoobrashcheniye. 1988;2:43–45. (In Russ.)
  14. Urakov AL, Odiyankov YeG, Odiyankov YuG, et al. Mestnaya gipotermiya v lechenii ostroy neprokhodimosti arteriy konechnosti. Vestnik khirurgii imeni I.I.Grekova. 1988;7:62–65. (In Russ.)
  15. Murav’yev MF, Odiyankov YeG, Urakov AL, et al. Farmakokholodovaya terapiya pri tyazheloy khronicheskoy ishemii nizhnikh konechnostey. Khirurgiya. 1989;3:25–29. (In Russ.)
  16. Shabanov PD, Fisher EL, Urakov AL. Hydrogen peroxide formulations and methods of their use for blood oxygen saturation. Journal of Medical Pharmaceutical and Allied Science. 2022;11(6):5489–5493. doi: 10.55522/jmpas.V11I6.4604
  17. Urakov A, Shabanov P, Lovtsova L. Development of new generation drugs by enriching them with gases. Journal of Pharmaceutical Research International. 2023;35(3):7–16. doi: 10.9734/jpri/2023/v35i37315
  18. Urakov A, Urakova N, Sorokina Yu, et al. Targeted modification of physical-chemical properties of drugs as a universal way to transform “old” drugs into “new” drugs. In: Drug repurposing — advances, scopes and opportunities in drug discovery. Chapter 3. Ed. by M. Rudrapal. 2023. doi: 10.5772/intechopen.110480
  19. Urakov A, Urakova N, Reshetnikov A, et al. Reprofiling hydrogen peroxide from antiseptics to pyolytics: a narrative overview of the history of inventions in Russia. Journal of Pharmaceutical Research International. 2023;35(6):37–48. doi: 10.9734/jpri/2023/v35i67333
  20. Urakov A, Shabanov P, Gurevich K, et al. Intrapulmonary use of hydrogen peroxide in respiratory obstruction: Initial results demonstrate the possibility of airway recanalization and blood reoxygenation through the lungs: an update. Journal of Pharmaceutical Research International. 2023;35(9):33–37. doi: 10.9734/jpri/2023/v35i97348
  21. Urakov AL, Urakova NA, Shubina ZV, et al. Hypertonic Activity of Injection Solutions Can Cause Post-injection Complications (Review). Drug development & registration. 2023;12(2):164–173. (In Russ.) doi: 10.33380/2305-2066-2023-12-2-164-173
  22. Urakov AL, Shabanov PD, Gurevich KG, et al. Supplementing traditional drug formulation with the “needed” gases opens the way for the development of a new generation of drugs. Psychopharmacology & biological narcology. 2023;14(1):5–14. (In Russ.) doi: 10.17816/phbn321616
  23. Urakov AL, Urakova NA, Stolyarenko AP. How to turn an old medicine into a new medicine. Journal of Bio Innovation. 2020; 9(5):774–777. doi: 10.46344/JBINO.2020.v09i05.13
  24. Urakov AL, Urakova NA, Kozlova TS. Lokal’naya toksichnost’ lekarstv kak pokazatel’ ikh veroyatnoy agressivnosti pri mestnom primenenii. Vestnik Ural’skoy meditsinskoy akademicheskoy nauki. 2011;1(33):105–108.
  25. Viter VI, Urakov AL, Pozdeev AR, et al. Evaluation of post-injection complications in forensic medical practice. Sudebnaya ekspertiza. 2013;1(33):79–89. (In Russ.)
  26. Miroshnichenko II, Valdman EA, Kuz’min II. Old drugs, new indications (review). Drug development & registration. 2023;12(1):182–190. (In Russ.) doi: 10.33380/2305-2066-2023-12-1-182-190

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 84654 от 01.02.2023 г

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies